Eleven P15 Inc.

DENVER, CO · Founded 2016 · Medtech · Private

Diagnostic and therapeutic platform for pulmonary fibrosis

Claim this profile

Follows are private to you and power your alerts

Updated · elevenp15.com

Sector
Medtech
Headquarters
DENVER, CO
Founded
2016
Latest Form D
$1.6M, Nov 2019
Total capital
$1.6M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$1.6M
1 Form D · last Nov 2019
83 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
1 pending

Capital timeline

2019FEDERAL ↑EQUITY ↓Cumulative $1.6M1st Form D$1.6M
2019FEDERAL ↑EQUITY ↓Cumulative $1.6M1st Form D$1.6M

Latest events

  • Private capital raisedForm D · SEC · 1st filing$1.6M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

From SEC Form D filings
  • Bruce SchroffelExecutive OfficerNamed in SEC Form D filings
  • David SchwartzExecutive Officer, Director, PromoterNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 1
  • PendingCirculating Biomarkers Of Preclinical Pulmonary FibrosisUSPTOApplication PCTUS2020033467
  • NEXGEL, INC.Similar federal contract value in Medtech · null in contracts
  • GLIMPSE DIAGNOSTICS, INC.Similar federal contract value in Medtech · null in contracts
  • SkinIO, Inc.Similar federal contract value in Medtech · null in contracts
  • VuEssence, Inc.Similar federal contract value in Medtech · null in contracts
  • OMNISEQ, INC.Similar federal contract value in Medtech · null in contracts
  • IC Surgical, Inc.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .